Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure.

Muhammad Akram; W Waratchareeyakul; T Kaserer; J Haupenthal; RW Hartmann; Daniela Brigitte Schuster

Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure.

Muhammad Akram, W Waratchareeyakul, T Kaserer, J Haupenthal, RW Hartmann, Daniela Brigitte Schuster

Insitute of Pharmacy

Research output: Contribution to conference › Poster

Original language	Undefined/Unknown
Publication status	Published - 2017
Event	PHARMA 2030 – CURRENT AND FUTURE CHALLENGES - University of Innsbruck, Austria Duration: 20 Apr 2017 → 22 Apr 2017

Conference with scientific content

Conference with scientific content	PHARMA 2030 – CURRENT AND FUTURE CHALLENGES
Country/Territory	Austria
City	University of Innsbruck
Period	20/04/17 → 22/04/17

1 Abstract

Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure.
Akram, M., Waratchareeyakul, W., Kaserer, T., Haupenthal, J., Hartmann, R. & Schuster, D. B., 2017.
Research output: Contribution to conference › Abstract

Cite this

Akram, M., Waratchareeyakul, W., Kaserer, T., Haupenthal, J., Hartmann, RW., & Schuster, D. B. (2017). Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure. . Poster session presented at PHARMA 2030 – CURRENT AND FUTURE CHALLENGES, University of Innsbruck, Austria.

@conference{01e796c53ff04b34aebe8d791f2e5a2a,

title = "Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure. ",

author = "Muhammad Akram and W Waratchareeyakul and T Kaserer and J Haupenthal and RW Hartmann and Schuster, {Daniela Brigitte}",

year = "2017",

language = "Undefined/Unknown",

note = "PHARMA 2030 – CURRENT AND FUTURE CHALLENGES ; Conference date: 20-04-2017 Through 22-04-2017",

}

Akram, M, Waratchareeyakul, W, Kaserer, T, Haupenthal, J, Hartmann, RW & Schuster, DB 2017, 'Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure. ', PHARMA 2030 – CURRENT AND FUTURE CHALLENGES, University of Innsbruck, Austria, 20/04/17 - 22/04/17.

Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure. . / Akram, Muhammad; Waratchareeyakul, W; Kaserer, T et al.
2017. Poster session presented at PHARMA 2030 – CURRENT AND FUTURE CHALLENGES, University of Innsbruck, Austria.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure.

AU - Akram, Muhammad

AU - Waratchareeyakul, W

AU - Kaserer, T

AU - Haupenthal, J

AU - Hartmann, RW

AU - Schuster, Daniela Brigitte

PY - 2017

Y1 - 2017

M3 - Poster

T2 - PHARMA 2030 – CURRENT AND FUTURE CHALLENGES

Y2 - 20 April 2017 through 22 April 2017

ER -

Akram M, Waratchareeyakul W, Kaserer T, Haupenthal J, Hartmann RW, Schuster DB. Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure. . 2017. Poster session presented at PHARMA 2030 – CURRENT AND FUTURE CHALLENGES, University of Innsbruck, Austria.